Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Radiotherapy‐to‐Surgery Interval After Induction Total Neoadjuvant Therapy for Rectal Cancer: Perioperative Outcomes and Oncologic Quality of Total Mesorectal Excision. Local targets link to admitted publications; unresolved targets remain external evidence.
Short‐Course Radiotherapy Followed by Chemotherapy before Total Mesorectal Excision (TME) Versus Preoperative Chemoradiotherapy, TME, and Optional Adjuvant Chemotherapy in Locally Advanced Rectal Cancer (RAPIDO): A Randomised, Open‐Label, Phase 3 Trial
10.1016/s1470-2045(20)30555-6 · 2021 · External reference
Neoadjuvant Chemotherapy with FOLFIRINOX and Preoperative Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer (UNICANCER‐PRODIGE 23): A Multicentre, Randomised, Open‐Label, Phase 3 Trial
10.1016/s1470-2045(21)00079-6 · 2021 · External reference
Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy
10.1200/jco.22.00032 · 2022 · External reference
10.1200/jco.23.01208
10.1200/jco.23.01208 · External reference
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO‐12
10.1200/jco.19.00308 · 2019 · External reference
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long‐Term Results of the CAO/ARO/AIO‐12 Randomized Clinical Trial
10.1001/jamaoncol.2021.5445 · 2022 · External reference
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines
10.6004/jnccn.2024.0041 · 2024 · External reference
International Consensus Recommendations on Key Outcome Measures for Organ Preservation After (Chemo)Radiotherapy in Patients With Rectal Cancer
10.1038/s41571-021-00538-5 · 2021 · External reference
10.1016/j.annonc.2025.05.528
10.1016/j.annonc.2025.05.528 · External reference
10.1200/jco.24.01160
10.1200/jco.24.01160 · External reference
10.1016/j.prro.2024.11.003
10.1016/j.prro.2024.11.003 · External reference
Effect of Interval (7 or 11 Weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR‐6)
10.1200/jco.2016.67.6049 · 2016 · External reference
Optimal Fractionation of Preoperative Radiotherapy and Timing to Surgery for Rectal Cancer (Stockholm III): A Multicentre, Randomised, Non‐Blinded, Phase 3, Non‐Inferiority Trial
10.1016/s1470-2045(17)30086-4 · 2017 · External reference
Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta‐Analysis of Published Studies
10.1097/sla.0000000000000368 · 2016 · External reference
Optimal Time Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Rectal Cancer
10.1002/bjs.9112 · 2013 · External reference
10.1016/j.surge.2024.03.001
10.1016/j.surge.2024.03.001 · External reference
10.1007/s11605-023-05601-3
10.1007/s11605-023-05601-3 · External reference
10.1097/sla.0000000000003885
10.1097/sla.0000000000003885 · External reference
10.1097/dcr.0000000000002555
10.1097/dcr.0000000000002555 · External reference
10.1002/cam4.4582
10.1002/cam4.4582 · External reference
Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6,336 Patients
2004 · External reference
Definition and Grading of Anastomotic Leakage Following Anterior Resection of the Rectum: A Proposal by the International Study Group of Rectal Cancer
10.1016/j.surg.2009.10.012 · 2010 · External reference
Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control
10.1200/jco.2002.07.010 · 2002 · External reference
10.1016/s1470-2045(21)00493-9
10.1016/s1470-2045(21)00493-9 · External reference
